Healthy Living Maine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maine.

Press releases published on June 1, 2026

7 hours ago

La Société canadienne de la SLA met en avant les avancées de la recherche et appelle à poursuivre la lutte pendant ce mois de la sensibilisation à la SLA

Indeterminate GlobeNewswire

7 hours ago

Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches

Indeterminate GlobeNewswire

7 hours ago

Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

7 hours ago

MDA Expands 2026 Engage Symposium Series, Bringing the Neuromuscular Community Together in Four U.S. Cities

Indeterminate GlobeNewswire

7 hours ago

Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus

Indeterminate GlobeNewswire

7 hours ago

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

Indeterminate GlobeNewswire

7 hours ago

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

Indeterminate GlobeNewswire

7 hours ago

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

7 hours ago

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

Indeterminate GlobeNewswire

7 hours ago

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

Indeterminate GlobeNewswire

7 hours ago

Wave Life Sciences to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

7 hours ago

Oak Hill Bio Raises $32.5 Million Series A Financing to Advance Antisense Oligonucleotide Therapy Rugonersen to Phase 3 Study in Angelman Syndrome

Indeterminate GlobeNewswire

7 hours ago

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

Indeterminate GlobeNewswire

7 hours ago

How Advanced Drug Delivery Could Improve Existing Cancer Treatments

Indeterminate GlobeNewswire

7 hours ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

7 hours ago

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire

7 hours ago

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Indeterminate GlobeNewswire

7 hours ago

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Indeterminate GlobeNewswire

7 hours ago

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Indeterminate GlobeNewswire

7 hours ago

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Indeterminate GlobeNewswire